HOWL News

The IPO market stayed active this past week with seven IPOs raising $1.9 billion. One company withdrew ahead of its expected pricing, specialty insurer The Fortegra Group (FRF). SPAC activity picked up slightly, with three blank check IPOs raising $560 million. New filers took a breather, with six IPOs and five SPACs submitting initial filings. Entertainment...read more

Werewolf Therapeutics, a preclinical biotech developing immune therapies for cancer, raised $120 million by offering an upsized 7.5 million shares at $16, the midpoint of the $15 to $17 range. The company originally planned to offer 6.3 million shares. At pricing, Werewolf Therapeutics commands a fully diluted market cap of $470 million.  The company's lead candidates, WTX...read more

Werewolf Therapeutics, a preclinical biotech developing immune therapies for cancer, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpoint of the proposed range, Werewolf Therapeutics would command a fully diluted market value of $450 million.  ...read more

Updated Monday, 4/26. With the end of April on the horizon, seven IPOs are currently slated to raise $2.2 billion in the week ahead. The diverse group features a home care provider, a talent agency, and more. Home care provider Aveanna Healthcare Holdings (AVAH) plans to raise $650 million at a $3.2 billion market cap. Aveanna’s clinical...read more